Scientists Use Gene Therapy to Tackle Oral Herpes in Mice
MONDAY, Aug. 31, 2020 -- Gene therapy has nearly eliminated the oral herpes virus in lab animals, researchers report.
Using a gene editing technique, they achieved at least a 90% reduction in latent herpes simplex virus 1 (HSV-1) in mice, which... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 31, 2020 Category: General Medicine Source Type: news
New gene therapy approach eliminates at least 90% latent herpes simplex virus 1
(Fred Hutchinson Cancer Research Center) Infectious disease researchers at Fred Hutchinson Cancer Research Center have used a gene editing approach to remove latent herpes simplex virus 1, or HSV-1, also known as oral herpes. In animal models, the findings show at least a 90 percent decrease in the latent virus, enough researchers expect that it will keep the infection from coming back. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 18, 2020 Category: Infectious Diseases Source Type: news
Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients
Basel, 5 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has authorised the cobas ® EBV test. This is the first quantitative in vitro diagnostic test for Epstein-Barr virus (EBV) DNA in the United States. This authorisation gives healthcare professionals a key tool in monitoring transplant patients at risk for complications from infections or reactivations of EBV, by providing t he ability to run a large number of patient tests for this virus in a short period of time.“Monitoring of Epstein-Barr virus DNA can help prevent progression of life-threatening d...
Source: Roche Media News - August 5, 2020 Category: Pharmaceuticals Source Type: news
Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients
Basel, 5 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has authorised the cobas ® EBV test. This is the first quantitative in vitro diagnostic test for Epstein-Barr virus (EBV) DNA in the United States. This authorisation gives healthcare professionals a key tool in monitoring transplant patients at risk for complications from infections or reactivations of EBV, by providing t he ability to run a large number of patient tests for this virus in a short period of time.“Monitoring of Epstein-Barr virus DNA can help prevent progression of life-threatening d...
Source: Roche Investor Update - August 5, 2020 Category: Pharmaceuticals Source Type: news
Resistance Is Futile: Is This Herpes Treatment The Future For Antivirals?
A Swedish research team has discovered a new way to tackle herpes viruses that avoids the development of drug resistance. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 3, 2020 Category: Pharmaceuticals Authors: Mariella Attard, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Epidemiology of Herpes Simplex Virus in Europe Transitioning
WEDNESDAY, July 22, 2020 -- The epidemiology of herpes simplex virus (HSV)-1 is transitioning away from oral acquisition in childhood with an increasing proportion of HSV-1 detection in genital herpes, according to a study published online July 16... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 22, 2020 Category: Pharmaceuticals Source Type: news
TREMFYA ® (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis
HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] TREMFYA is the first treatment approved for active PsA that selectively inhibits interleukin (IL)-23, a naturally occurring cytokine that is involved in normal inflammatory and immune responses associated with the symptoms of PsA. The safety and efficacy of TREMFYA in PsA have been dem...
Source: Johnson and Johnson - July 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Ultrasound-Mediated Transdermal Medication May Relieve Zoster-Associated Allodynia Ultrasound-Mediated Transdermal Medication May Relieve Zoster-Associated Allodynia
Ultrasound-mediated transdermal lidocaine and capsaicin appears to relieve pain and emotional distress related to allodynia caused by herpes zoster, researchers in China report.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 7, 2020 Category: Radiology Tags: Infectious Diseases News Source Type: news
Pioneering Molecular Biologist Dies of COVID-19 at 89 Pioneering Molecular Biologist Dies of COVID-19 at 89
In addition to receiving a patent in molecular biology, Evelyn Carmon Nicol made discoveries concerning toxoplasmosis, herpes zoster, and HIV during her 4-decade career.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 1, 2020 Category: Infectious Diseases Tags: Pathology & Lab Medicine News Source Type: news
Herpes Zoster Infection With MS Treatment Higher in Women? Herpes Zoster Infection With MS Treatment Higher in Women?
A review of FDA reports also shows notably higher rates of shingles in women among younger patients taking disease-modifying therapies for multiple sclerosis.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 4, 2020 Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news
Unusual Symptoms of Coronavirus: What We Know So Far
While most people are familiar with the hallmark symptoms of COVID-19 by now—cough, fever, muscle aches, headaches and difficulty breathing—a new crop of medical conditions are emerging from the more than 4 million confirmed cases of the disease around the world.
These include skin rashes, diarrhea, kidney abnormalities and potentially life-threatening blood clots. It’s not unusual for viruses to directly infect and affect different tissues and organs in the body, but it is a bit unusual for a primarily respiratory virus like SARS-CoV-2, which is responsible for COVID-19, to have such a wide-ranging reach...
Source: TIME: Health - May 19, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
What Are Potential Complications of Tattooing?
Discussion
“Tattooing of skin via deposition of pigment particles and ink ingredients in the dermis changes normal skin into abnormal skin. Fortunately, this often causes no harm and no disease, although with important exceptions.” Tattoos can be inadvertent from road dirt, gunpowder, pencil graphite etc., but most are desired. Tattoos are common in many cultures and over time..They have been increasing in popularity in the United States over the past few years particularly with a younger, wider and more diverse population.
Newsweek reported an 18-country study in 2018 which showed 46% of Americans have a tat...
Source: PediatricEducation.org - May 18, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Brain model links herpes virus to development of Alzheimer's disease
Bio-engineered models of the human brain infected with herpes simplex virus-1 develop many of the same characteristics found in Alzheimer's disease, according to a new analysis published by Science Advances. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 6, 2020 Category: Consumer Health News Source Type: news
Herpes Virus Yields Up Genetic Secrets
Title: Herpes Virus Yields Up Genetic SecretsCategory: Health NewsCreated: 4/29/2020 12:00:00 AMLast Editorial Review: 4/30/2020 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - April 30, 2020 Category: Dermatology Source Type: news
Herpes Virus Yields Up Genetic Secrets
(Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - April 29, 2020 Category: Reproduction Medicine Tags: Reproductive Medicine, Research, News, Source Type: news
